GL1X · GenesisL1 explorer

MolNFT v1 · #148018 · protein

Butyrylcolinesterase expressed in cho cells co-crystallised with a rivastigmine analogue

6EUL · Cholinesterase: “Butyrylcolinesterase expressed in cho cells co-crystallised with a rivastigmine analogue”. X-ray diffraction, 2 ligands (BY2, NAG), 5 pockets (best druggability 0.77). MolNFT v1 #148018 on GenesisL1: 3D structure…

PDB
6EUL
Type
protein
Length
527 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cholinesterase
EC
3.1.1.8
UniProt
P06276
Ligands
BY2, NAG
Pockets
5 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACholinesterase (EC 3.1.1.8)protein52736% helix, 17% strandP06276

Ligands and binding sites

  • BY2 · [3-[(1~{R})-1-(dimethylamino)ethyl]-4-oxidanyl-phenyl] ~{N}-ethyl-~{N}-methyl-carbamate · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14460.770.8640BY2, EDO
24590.640.7744empty
3590.380.7917empty
4770.360.7617empty
5780.320.7417empty

Modifications

Observed in the structure: 3 disulfide, 3 glycan, 1 modified (disulfide, N-glycosylation, nonstandard).

Compared structures

  • P06276 · AlphaFold monomer V2.0 prediction for cholinesterase (P06276) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.